These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 16164920)

  • 41. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
    Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
    Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.
    Dominguez FJ; Golshan M; Black DM; Hughes KS; Gadd MA; Christian R; Lesnikoski BA; Specht M; Michaelson J; Smith BL
    Ann Surg Oncol; 2008 Jan; 15(1):268-73. PubMed ID: 17891441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sentinel lymph node metastasis in microinvasive breast cancer.
    Intra M; Zurrida S; Maffini F; Sonzogni A; Trifirò G; Gennari R; Arnone P; Bassani G; Opazo A; Paganelli G; Viale G; Veronesi U
    Ann Surg Oncol; 2003 Dec; 10(10):1160-5. PubMed ID: 14654471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
    de Mascarel I; MacGrogan G; Mathoulin-Pélissier S; Soubeyran I; Picot V; Coindre JM
    Cancer; 2002 Apr; 94(8):2134-42. PubMed ID: 12001109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review.
    van Deurzen CH; Hobbelink MG; van Hillegersberg R; van Diest PJ
    Eur J Cancer; 2007 Apr; 43(6):993-1001. PubMed ID: 17300928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
    Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
    Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast.
    Usmani S; Khan HA; Al Saleh N; abu Huda F; Marafi F; Amanguno HG; Al Nafisi N; Al Kandari F
    Nucl Med Commun; 2011 Nov; 32(11):1084-7. PubMed ID: 21862942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An argument against routine sentinel node mapping for DCIS.
    Farkas EA; Stolier AJ; Teng SC; Bolton JS; Fuhrman GM
    Am Surg; 2004 Jan; 70(1):13-7; discussion 17-8. PubMed ID: 14964539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida.
    Camp R; Feezor R; Kasraeian A; Cendan J; Schell S; Wilkinson E; Copeland E; Lind S
    Breast J; 2005; 11(6):394-7. PubMed ID: 16297082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
    Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
    Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsy.
    Rokutanda N; Horiguchi J; Koibuchi Y; Nagaoka R; Sato A; Odawara H; Tokiniwa H; Iino Y; Hirato J; Takeyoshi I
    Breast Cancer; 2009; 16(2):162-5. PubMed ID: 19242778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
    Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
    J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 54. Is it possible to refine the indication for sentinel node biopsy in high-risk ductal carcinoma in situ?
    Fraile M; Gubern JM; Rull M; Julián FJ; Serra C; Llatjós M; Culell P; Puig P; Solà M; Vallejos V; Mariscal A; Janer J; Deulofeu P; Fusté F
    Nucl Med Commun; 2006 Oct; 27(10):785-9. PubMed ID: 16969260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
    Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sentinel node biopsy in ductal carcinoma in situ patients.
    Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS
    Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.
    Tunon-de-Lara C; Chauvet MP; Baranzelli MC; Baron M; Piquenot J; Le-Bouédec G; Penault-Llorca F; Garbay JR; Blanchot J; Mollard J; Maisongrosse V; Mathoulin-Pélissier S; MacGrogan G
    Ann Surg Oncol; 2015 Nov; 22(12):3853-60. PubMed ID: 25777085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of sentinel lymph node biopsy in ductal carcinoma in situ.
    Schneider C; Trocha S; McKinley B; Shaw J; Bielby S; Blackhurst D; Jones Y; Cornett W
    Am Surg; 2010 Sep; 76(9):943-6. PubMed ID: 20836339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prediction of lymph node metastasis in ductal carcinoma in situ with microinvasion by assessing lymphangiogenesis.
    Lee SK; Cho EY; Kim WW; Kim SH; Hur SM; Kim S; Choe JH; Kim JH; Kim JS; Lee JE; Nam SJ; Yang JH
    J Surg Oncol; 2010 Sep; 102(3):225-9. PubMed ID: 20740579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.